| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fennec Pharmaceuticals Inc. (FENC) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. FENC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.74M | $18.58M | - | |
| CFO | 826.6K | $5.60M | - | |
| Dir | 225.0K | $1.52M | - | |
| Dir | 215.5K | $1.46M | - | |
| Dir | 174.3K | $1.18M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2024 | Raykov Rosty55 | Chief Executive Officer | Sell | 2,431 | $6.26 | $15,205.90 | -1.3% | -28.7% | +25.0% | |
| Jul 5, 2024 | Rallis Chris A62 | Director | Sale+OE | 1,173 | $6.03 | $7,073.19 | -2.5% | -22.2% | +45.8% | |
| Jul 2, 2024 | Raykov Rosty55 | Chief Executive Officer | Sell | 2,431 | $6.13 | $14,902.03 | -1.3% | -17.1% | +41.6% | |
| Jun 3, 2024 | Raykov Rosty55 | Chief Executive Officer | Sell | 2,431 | $6.76 | $16,433.56 | -1.3% | -16.6% | +17.0% | |
| May 1, 2024 | Raykov Rosty55 | Chief Executive Officer | Sell | 2,431 | $9.11 | $22,152.00 | -1.3% | -30.4% | -32.8% | |
| Apr 22, 2024 | Haigh Adrian79 | Chief Operating Officer | Sale+OE | 44,445 | $9.33 | $414,471.84 | -100% | -30.0% | -42.0% | |
| Apr 18, 2024 | Haigh Adrian79 | Chief Operating Officer | Sale+OE | 88,888 | $6.04 | $536,661.30 | -50.0% | -30.5% | -46.9% | |
| Apr 16, 2024 | Haigh Adrian79 | Chief Operating Officer | Sale+OE | 88,888 | $6.30 | $559,847.73 | -50.0% | -36.3% | -50.3% | |
| Apr 15, 2024 | Rallis Chris A62 | Director | Sale+OE | 800 | $10.45 | $8,360.00 | -1.8% | -36.7% | -49.2% | |
| Apr 5, 2024 | Raykov Rosty55 | Chief Executive Officer | Sell | 88,583 | $10.82 | $958,668.92 | -11.5% | -45.7% | -50.9% |